Ocena substancji – wspólnotowy kroczący plan działań

Ocena substancji – wspólnotowy kroczący plan działań

Ocena substancji – wspólnotowy kroczący plan działań

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
Suspected PMT/vPvM: Potentially Persistent, Mobile and Toxic/very Persistent and very Mobile.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 22 marca 2024. Database contains 402 unique substances/entries.
Filter the list
Initial grounds for concern:

The List does not contain any Substances.
 
204-442-7
121-00-6
2015
France
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of sensitive populations
Wide dispersive use
Conclusion under preparation
Details
202-112-7
91-97-4
2013
France
Suspected CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Concluded
Details
201-126-0
78-59-1
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
201-052-9
77-73-6
2016
France
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
High RCR
Concluded
Details
201-618-5
85-60-9
2019
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Information requested
Details
247-118-0
25584-83-2
2025
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Sensitiser
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Not started
Details
231-208-1
7446-70-0
2015
France
Suspected CMR
Exposure of workers
High (aggregated) tonnage
High RCR
Follow-up
Details
215-477-2
1327-41-9
2015
France
Suspected CMR
High (aggregated) tonnage
Follow-up
Details
233-135-0
10043-01-3
2015
France
Suspected CMR
Suspected Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Follow-up
Details
202-860-4
100-52-7
2025
France
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Not started
Details
931-700-2
-
2026
France
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
237-695-7
13927-71-4
2020
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of workers
Suspended
Details
308-662-5
98171-53-0
2023
France
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of workers
Ongoing
Details
215-609-9
1333-86-4
2026
France
Carcinogenic
Suspected Reprotoxic
Consumer use
Cumulative exposure
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
200-843-6
75-15-0
2013
France
CMR
Potential endocrine disruptor
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Concluded
Details
200-262-8
56-23-5
2012
France
CMR
Exposure of workers
High (aggregated) tonnage
Concluded
Details
215-160-9
1308-38-9
2019
France
Suspected Reprotoxic
Suspected Sensitiser
High (aggregated) tonnage
Concluded
Details
200-467-2
60-29-7
2025
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
941-303-6
-
2026
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Not started
Details
200-001-8
50-00-0
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
248-666-3
27813-02-1
2014
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
202-785-7
99-76-3
2014
France
CMR
Potential endocrine disruptor
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
201-297-1
80-62-6
2014
France
Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
204-317-7
119-36-8
2015
France
Suspected CMR
Consumer use
High (aggregated) tonnage
Concluded
Details
214-263-6
1118-46-3
2018
France
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Suspended
Details
228-250-8
6197-30-4
2012
France
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
272-486-4
68855-45-8
2016
France
CMR
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
231-760-3
7722-64-7
2017
France
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
Concluded
Details
432-240-0
12056-51-8
2017
France
Carcinogenic
Exposure of workers
Information requested
Details
905-459-9
-
2025
France
Suspected Reprotoxic
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Not started
Details
915-730-3
-
2017
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Information requested
Details
701-337-2
-
2020
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
939-505-4
-
2023
France
Potential endocrine disruptor
Exposure of environment
Ongoing
Details
ADDITIV 104
412-780-3
1380226-46-9
France
Suspected PBT/vPvB
Concluded
Details
701-385-4
-
2021
France
Suspected Mutagenic
Suspected PBT/vPvB
High (aggregated) tonnage
Information requested
Details
203-585-2
108-46-3
2019
France
Potential endocrine disruptor
High (aggregated) tonnage
Information requested
Details
216-653-1
1634-04-4
2014
France
Potential endocrine disruptor
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
257-573-7
51981-21-6
2024
France
Suspected Carcinogenic
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
231-302-2
7488-55-3
2016
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
Concluded
Details
236-675-5
13463-67-7
2018
France
Carcinogenic
Suspected Mutagenic
Other hazard based concern
Information requested
Details
202-924-1
101-20-2
2019
France
Suspected Reprotoxic
Potential endocrine disruptor
Wide dispersive use
Concluded
Details
204-112-2
115-86-6
2017
France
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
701-028-2
-
2013
France
Suspected PBT/vPvB
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
247-156-8
25640-78-2
Germany
Suspected PBT/vPvB
Wide dispersive use
Withdrawn
Details
701-394-3
1782069-81-1
2020
Germany
Potential endocrine disruptor
Concluded
Details
306-832-3
97416-84-7
2017
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
244-617-5
21850-44-2
2017
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
-
37486-69-4
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
258-904-8
53988-10-6
2018
Germany
Potential endocrine disruptor
Exposure of environment
Concluded
Details
262-872-0
61617-00-3
2018
Germany
Potential endocrine disruptor
Exposure of environment
Concluded
Details
211-463-5
646-06-0
2016
Germany
Suspected Mutagenic
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
273-227-8
68953-84-4
2013
Germany
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
219-372-2
2425-85-6
2019
Germany
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
EC No. 216-133-4 and EC No. 244-240-6
show/hide
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one EC / List no: 244-240-6 | CAS no: 21145-77-7
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one EC / List no: 216-133-4 | CAS no: 1506-02-1
-
-
2020
Germany
Potential endocrine disruptor
High (aggregated) tonnage
Information requested
Details
222-429-4
3468-63-1
2019
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Wide dispersive use
Concluded
Details
220-562-2
2814-77-9
2019
Germany
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
274-581-6
70356-09-1
2015
Germany
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
926-564-6
-
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
229-962-1
6864-37-5
2015
Germany
Potential endocrine disruptor
Concluded
Details
203-868-0
111-42-2
2012
Germany
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
249-820-2
29736-75-2
2018
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Other hazard based concern
Exposure of workers
Follow-up
Details
266-733-5
67584-55-8
2018
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Concluded
Details
204-263-4
118-60-5
Germany
Potential endocrine disruptor
Withdrawn
Details
629-661-9
83834-59-7
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
241-527-8
17527-29-6
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Concluded
Details
218-407-9
2144-53-8
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Concluded
Details
253-781-7
38103-06-9
2013
Germany
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
201-240-0
79-97-0
2021
Germany
Suspected Reprotoxic
Potential endocrine disruptor
Information requested
Details
Bisphenol A; BPA
201-245-8
80-05-7
2012
Germany
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
233-593-1
10254-57-6
Germany
Suspected PBT/vPvB
Withdrawn
Details
202-679-0
98-54-4
2014
Germany
Potential endocrine disruptor
High (aggregated) tonnage
Concluded
Details
800-353-8
1379524-06-7
2016
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
High RCR
Wide dispersive use
Concluded
Details
480-310-4
-
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
700-242-3
62037-80-3
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
700-323-3
908020-52-0
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
232-235-1
7790-98-9
2015
Germany
Suspected Carcinogenic
Potential endocrine disruptor
Other hazard based concern
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
231-146-5
7440-36-0
2018
Germany
Suspected Carcinogenic
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Follow-up
Details
215-713-4
1345-04-6
2018
Germany
Suspected Carcinogenic
Exposure of workers
High RCR
Other exposure/risk based concern
Wide dispersive use
Follow-up
Details
233-047-2
10025-91-9
2018
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Concluded
Details
225-935-3
5160-02-1
2020
Germany
Suspected Carcinogenic
Exposure of workers
Wide dispersive use
Concluded
Details
270-128-1
68411-46-1
2016
Germany
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
309-912-6
101357-15-7
2019
Germany
Suspected PBT/vPvB
Concluded
Details
205-736-8
149-30-4
2013
Germany
CMR
Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-394-1
95-14-7
2016
Germany
Potential endocrine disruptor
Exposure of environment
Concluded
Details
202-859-9
100-51-6
2016
Germany
Suspected Sensitiser
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
204-262-9
118-58-1
Germany
Potential endocrine disruptor
Withdrawn
Details
231-150-7
7440-41-7
2013
Germany
Other exposure/risk based concern
Concluded
Details
421-450-8
154702-15-5
2015
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
258-469-4
53306-54-0
2020
Germany
Potential endocrine disruptor
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
700-183-3
52299-25-9
2018
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Concluded
Details
243-001-3
19372-44-2
2015
Germany
Sensitiser
Other hazard based concern
Exposure of workers
High (aggregated) tonnage
Concluded
Details
609-946-4
41637-38-1
Germany
Suspected PBT/vPvB
Exposure of environment
Withdrawn
Details
203-450-8
106-99-0
2014
Germany
CMR
Other exposure/risk based concern
Concluded
Details
202-496-6
96-29-7
2013
Germany
CMR
Sensitiser
Consumer use
Cumulative exposure
High RCR
Wide dispersive use
Concluded
Details
215-150-4
1306-38-3
Germany
Suspected Carcinogenic
Suspected Mutagenic
Other hazard based concern
Cumulative exposure
Exposure of environment
Wide dispersive use
Withdrawn
Details
201-248-4
80-08-0
2016
Germany
Potential endocrine disruptor
Concluded
Details
229-782-3
6731-36-8
2014
Germany
Suspected PBT/vPvB
Information requested
Details
215-175-0
1309-64-4
2018
Germany
Carcinogenic
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Information requested
Details
201-550-6
84-66-2
2014
Germany
CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
210-871-0
624-92-0
2014
Germany
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details

Export search results to: